Henry: Cancer Management in Small Animal Practice

Chapter 1: Pathophysiology and Tumor Cell Growth

References

  1. Tannock IF, Hill RP, Bristow RG, et al: The basic science of oncology, ed 4. New York, 2005, McGraw-Hill.
  2. Pelangaris S, Khan M: The molecular biology of cancer. Malden, 2006, Blackwell Publishing.
  3. DeVita VT, Hellman S, Rosenberg SA: Cancer: principles and practice of oncology, ed 7. Philadelphia, 2005, Lippincott, Williams & Wilkins.
  4. Balmain A, Gray J, Ponder B: The genetics and genomics of cancer, Nat Genet 33:238, 2003. Medline abstracts
  5. Hanahan D, Weinberg RA: The hallmarks of cancer, Cell 100:57, 2000. Medline abstracts
  6. Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes, Br J Cancer 94:179, 2006. Medline abstracts
  7. Jordan CT, Guzman ML, Noble M: Cancer stem cells, N Engl J Med 355:1253, 2006. Medline abstracts
  8. Mintz B, Illmensee K: Normal genetically mosaic mice produced from malignant teratocarcinoma cells, Proc Natl Acad Sci USA 72:3585, 1975. Medline abstracts
  9. Tessema M, Lehmann U, Kreipe H: Cell cycle and no end, Virchows Arch 444:313, 2004. Medline abstracts
  10. Dasika GK, Lin SC, Zhao S, et al: DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis, Oncogene 18:7883, 1999. Medline abstracts
  11. Spurgers KB, Chari NS, Bohnenstiehl NL, et al: Molecular mediators of cell death in multistep carcinogenesis: a path to targeted therapy, Cell Death Differ 13:1360, 2006. Medline abstracts
  12. Smalley KS, Brafford PA, Herlyn M: Selective evolutionary pressure from the tissue microenvironment drives tumor progression, Semin Cancer Biol 15:451, 2005. Medline abstracts
  13. Lou Z, Chen J: Cellular senescence and DNA repair, Exp Cell Res 312:2641, 2006. Medline abstracts
  14. Zhou J, Schmid T, Schnitzer S, et al: Tumor hypoxia and cancer progression, Cancer Lett 237:10, 2006. Medline abstracts
  15. Vogelstein B, Kinzler KW: Cancer genes and the pathways they control, Nat Med 10:789, 2004. Medline abstracts
  16. Fletcher JA: Role of KIT and platelet-derived growth factor receptors as oncoproteins, Semin Oncol 31:4, 2004. Medline abstracts
  17. Tsatsanis C, Spandidos DA: Oncogenic kinase signaling in human neoplasms, Ann N Y Acad Sci 1028:168, 2004. Medline abstracts
  18. Knudsen ES, Knudsen KE: Retinoblastoma tumor suppressor: where cancer meets the cell cycle, Exp Biol Med (Maywood) 231:1271, 2006. Medline abstracts
  19. Vousden KH, Lu X: Live or let die: the cell’s response to p53, Nat Rev Cancer 2:594, 2002. Medline abstracts
  20. Blackburn EH: Switching and signaling at the telomere, Cell 106:661, 2001. Medline abstracts
  21. Blandino G, Strano S: BCL-2: the pendulum of the cell fate, Exp Clin Cancer Res 16:3, 1997. Medline abstracts
  22. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges, Nat Med 12:895, 2006. Medline abstracts
  23. Gupta PB, Mani S, Yang J, et al: The evolving portrait of cancer metastasis, Cold Spring Harb Symp Quant Biol 70:291, 2005. Medline abstracts
  24. Ferrara N: VEGF and the quest for tumour angiogenesis factors, Nat Rev Cancer 2:795, 2002. Medline abstracts
  25. Esteller M: Aberrant DNA methylation as a cancer-inducing mechanism, Annu Rev Pharmacol Toxicol 45:629, 2005. Medline abstracts
  26. Belyaev N, Keohane AM, Turner BM: Differential underacetylation of histones H2A, H3 and H4 on the inactive X chromosome in human female cells, Hum Genet 97:573, 1996. Medline abstracts
  27. Kourmouli N, Jeppesen P, Mahadevhaiah S, et al: Heterochromatin and tri-methylated lysine 20 of histone H4 in animals, J Cell Sci 117:2491, 2004. Medline abstracts
  28. Lee YS, Dutta A: MicroRNAs: small but potent oncogenes or tumor suppressors, Curr Opin Investig Drugs 7:560, 2006. Medline abstracts
  29. Levine RA: Overexpression of the sis oncogene in a canine osteosarcoma cell line, Vet Pathol 39:411, 2002. Medline abstracts
  30. MacEwen EG, Pastor J, Kutzke J, et al: IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma, J Cell Biochem 92:77, 2004. Medline abstracts
  31. Kirpensteijn J, Timmermans-Sprang EP, van Garderen E, et al: Growth hormone gene expression in canine normal growth plates and spontaneous osteosarcoma, Mol Cell Endocrinol 197:179, 2002. Medline abstracts
  32. MacEwen EG, Kutzke J, Carew J, et al: c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells, Clin Exp Metastasis 20:421, 2003. Medline abstracts
  33. Mendoza S, Konishi T, Dernell WS, et al: Status of the p53, Rb and MDM2 genes in canine osteosarcoma, Anticancer Res 18:4449, 1998. Medline abstracts
  34. Hong SH, Ohashi E, Kadosawa T, et al: Retinoid receptors and the induction of apoptosis in canine osteosarcoma cells, J Vet Med Sci 62:469, 2000. Medline abstracts
  35. Mohammed SI, Coffman K, Glickman NW, et al: Prostaglandin E2 concentrations in naturally occurring canine cancer, Prostaglandins Leukot Essent Fatty Acids 64:1, 2001. Medline abstracts
  36. Koenig A, Bianco SR, Fosmire S, et al: Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma, Vet Pathol 39:458, 2002. Medline abstracts
  37. Levine RA, Forest T, Smith C: Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors, Vet Pathol 39:372, 2002. Medline abstracts
  38. Dickerson EB, Thomas R, Fosmire SP, et al: Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma, Vet Pathol 42:618, 2005. Medline abstracts
  39. Funakoshi Y, Nakayama H, Uetsuka K, et al: Cellular proliferative and telomerase activity in canine mammary gland tumors, Vet Pathol 37:177, 2000. Medline abstracts
  40. Platt SR, Scase TJ, Adams V, et al: Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival, J Vet Intern Med 20:663, 2006. Medline abstracts
  41. Maiolino P, De Vico G, Restucci B: Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin, J Comp Pathol 123:141, 2000. Medline abstracts
  42. Hirayama K, Yokota H, Onai R, et al: Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography, J Comp Pathol 127:249, 2002. Medline abstracts
  43. Loukopoulos P, O’Brien T, Ghoddusi M, et al: Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases, Res Vet Sci 77:131, 2004. Medline abstracts